SCHEMBL22908331

SCHEMBL22908331

CCCCN(CCCC)S(=O)(=O)c1ccc(CCN(Cc2cc(Cl)ccc2OC)C(=O)Cc2ccccc2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22908339 0.92 — —
SCHEMBL22908456 0.87 NLRP3 (0.53) —
SCHEMBL22908457 0.81 — —
SCHEMBL22908353 0.81 ALDH1A1 (0.51) —
SCHEMBL22908345 0.79 NLRP3 (0.55) —
SCHEMBL22908324 0.79 — —
SCHEMBL22908325 0.78 NLRP3 (0.54) —
SCHEMBL22908343 0.77 NLRP3 (0.56) —
SCHEMBL22908360 0.77 — —
SCHEMBL22908333 0.76 NLRP3 (0.51) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021011592-A1 COMPOUNDS AS NLRP3 INFLAMMASOME INHIBITORS AND COMPOSITIONS AND USES THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 2021-01-21 — — WO disclosed
Send feedback